Loading...
Investigation of the safety and feasibility of AAV1/SERCA2a gene transfer in patients with chronic heart failure supported with a left ventricular assist device – the SERCA-LVAD TRIAL
The SERCA-LVAD trial was a phase 2a trial assessing the safety and feasibility of delivering an adeno-associated vector 1 carrying the cardiac isoform of the sarcoplasmic reticulum calcium ATPase (AAV1/SERCA2a) to adult chronic heart failure patients implanted with a left ventricular assist device....
Na minha lista:
Udgivet i: | Gene Ther |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Nature Publishing Group UK
2020
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7744277/ https://ncbi.nlm.nih.gov/pubmed/32669717 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41434-020-0171-7 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|